EUVIMEDEUVIMED entdecken
Crossref

Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997

Xiang Li, Jinlong Ma, Zhenqian Sun, Na Li, Guangjun Jiao, Tianqi Zhang, Hongxin Cao

American Journal of Cancer Research · 2026 · 16 (10) · 4676-4678

DOI: 10.62347/inyp5017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Xiang Li und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, X., Ma, J., Sun, Z., Li, N., Jiao, G., Zhang, T., & Cao, H. (2026). Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997. American Journal of Cancer Research, 16(10), 4676-4678. https://doi.org/10.62347/inyp5017

Vancouver

Li X, Ma J, Sun Z, Li N, Jiao G, Zhang T, et al. Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997. American Journal of Cancer Research. 2026;16(10):4676-4678. doi:10.62347/inyp5017

BibTeX
@article{Li2026,
  author = {Li, Xiang and Ma, Jinlong and Sun, Zhenqian and Li, Na and Jiao, Guangjun and Zhang, Tianqi and Cao, Hongxin},
  title = {Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer: Am J Cancer Res. 2023; 13(7): 2984-2997},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {4676--4678},
  doi = {10.62347/inyp5017}
}
Kostenlos starten →